Heron Therapeutics, Inc.

NASDAQ:HRTX

Biotechnology

Healthcare
$0.26 +3.74%

+$0.01 today

Market cap
$50.25M
Beta
1.57
P/E (TTM)
-2.5
EPS (TTM)
-$0.16
52W Low $0.38High $2.30

Volume 3.60M

Average 2.90M

Price history

Heron Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-75.08%

Period high

$1.49

Period low

$0.26

Latest

$0.26

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
4Nov 10, 2026Nov 10, 2026
10-QNov 9, 2026Nov 9, 2026
8-KNov 9, 2026Nov 9, 2026
DEFA14ANov 9, 2026Nov 9, 2026
8-KNov 9, 2026Nov 9, 2026
DEFA14ANov 9, 2026Nov 9, 2026
4Nov 3, 2026Nov 3, 2026
4Nov 3, 2026Nov 3, 2026
4Nov 3, 2026Nov 3, 2026
4Nov 3, 2026Nov 3, 2026
S-8Oct 27, 2026Oct 27, 2026
4Oct 21, 2026Oct 21, 2026
4Oct 21, 2026Oct 21, 2026
4Oct 21, 2026Oct 21, 2026
8-KSep 29, 2026Sep 29, 2026

Competitors

Who does Heron Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about HRTX's filings, answered from its disclosures.

What is the latest HRTX filing?

The latest filing shown is 4 dated Nov 10, 2026.

How many recent filings does HRTX have?

Intrinsic Alpha currently shows 20 recent filings for HRTX.